Cephalon, Inc., (Nasdaq: CEPH) Receives FDA Approval for TREANDA, Treatment of Indolent Non-Hodgkin's Lymphoma - Video
MultiVu
Nov. 03, 2008. 09:47 AM EST
- RELATED CLIPS
-
FDA reverses Avastin approval
KSHB NBC 41 Kansas City
Nov. 21, 2011. 06:36 AM EST
-
Cephalon Probed by Department of Justice for Treanda
Financial News Network
Jul. 11, 2011. 02:32 PM EST
-
AstraZeneca Fails to Win FDA Approval; Cephalon CEO Dies
Bloomberg
Dec. 17, 2010. 11:25 AM EST
-
Last Line of Defense Fails Hodgkin's Lymphoma Patient
KRDO ABC 13 Colorado Spri
Dec. 17, 2010. 12:10 AM EST
-
Seattle Genetics' Siegall Discusses Lymphoma Treatment: Video
Bloomberg
Jun. 08, 2010. 12:24 PM EST
-
NEW MELANOMA TREATMENT NEARS FDA APPROVAL
KTVX ABC 4 Salt Lake City
Jun. 08, 2010. 08:15 AM EST
-
Cephalon's Nuvigil for Jet Lag Awaits FDA Approval: Video
Bloomberg
Jan. 08, 2010. 08:50 AM EST
-
N. Nevada solar project receives preliminary approval 1/5
KRNV Reno
Jan. 06, 2010. 11:24 AM EST
-
Novartis receives approval from FDA to market Prevacid® 24HR as fir...
MultiVu
May. 19, 2009. 01:44 PM EST
-
ALLERGAN ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL...
MultiVu
Dec. 29, 2008. 12:48 PM EST
